At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

With a market cap of $118.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing ...

Vertex Pharmaceuticals will soon lose a member ... three-quarters of which are in Massachusetts. The news was announced during the company's fourth quarter and full-year financial results on ...

Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

What to know about MA-based Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotech company based in Boston, Massachusetts. Its headquarters are in Boston's Seaport neighborhood, and it also ...

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company ... chief executive of the Massachusetts Association of Health Plans ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on ...

Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company ... Food and Drug Administration approved Vertex Pharmaceuticals‘s Journavx, known by the ...

BOSTON, February 18, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Stuart Arbuckle ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $470.37, demonstrating a +1.88% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing in the development of innovative therapies for serious diseases. Headquartered in Boston, Massachusetts ...